The concept of a risk related value of the spend for saving a statistical life (VSSSL) is advanced for use in cost-benefit studies across the power generation sector, and the nuclear industry in particular. For illustrative purposes, a best estimate VSSSL is set based on HSE guidance at £2 M. Above a risk of 10
−1
it is assumed that the VSSSL may approach this maximum sustainable value. As the risk reduces so does the VSSSL. At a risk level of 10 −6 y −1 a VSSSL of £0.5 M is applied. For risks below 10 −9 y −1 the value of further risk reduction approaches zero, although a nominal VSSSL of £10 k is applied as a pragmatic way forward in this study. The implications of adopting this concept as an aid to decision making in determining the spend on radiological dose reduction measures are illustrated through a worked example with a banded approach to estimating collective dose.
(Some figures in this article are in colour only in the electronic version)
Introduction
Ten years ago Roger Berry asked, in the context of ensuring adequate protection from ionising radiation, 'how low is low enough?' (Berry 1993) . It is a reasonable question. Clearly, for the early pioneers of the medical uses of radiation (both doctors and their patients) the visible harm they endured indicates that the standards of protection in place at the time had not kept doses low enough. Yet by the late 1940s in the UK it appeared that radiologists had a lower risk of death and/or malignant disease than the general population (Smith and Doll 1981) and by the late 1950s the excess cancer death risk amongst radiologists in the USA had also disappeared (Matanoski et al 1975) . Amongst workers in the UK nuclear industry the first report on the National Registry for Radiation Workers (NRRW) showed an overall deficit of deaths compared to expectation based on the whole UK population rates from all causes and, specifically, from all malignant neoplasms (Kendall et al 1992) . Although much has been said on the 'healthy worker' effect-a real cause of lower mortality rates amongst the workforce of many industries when compared to the general population-NRRW included 95 000 workers, many of whom had been employed during the 1940s and 1950s when radiation exposure levels could rise much higher than would be permitted in current operating plants. The second report on the NRRW (Muirhead et al 1999) , with an enlarged cohort of 125 000 workers and a longer follow-up period, also concluded that the mortality rates from all causes is 82% of that expected from national rates.
This does not mean that exposure to ionising radiation is without risk. Debate continues about the linear no-threshold (LNT) dose-risk response relationship (e.g. Higson 1999 , Wakeford 1999 ) at very low dose levels (i.e. below a few 10s of µSv). Nonetheless, it is clear that exposure to high level ionising radiation (i.e. above 200 mSv or so) substantially increases the risk of harm from fatal cancer induction (e.g. Pierce et al 1996) . Given the high background incidence of 'spontaneous' cancers it is probable that any deleterious (or hormetic) effect on human health arising from the discharge of low level radioactivity to the environment would be masked and it is partly because of the difficulty in determining the real risk of harm from low levels of exposure that the LNT hypothesis continues to be adopted in the regulation of the use of ionising radiation.
A strict interpretation of the LNT hypothesis means that any individual exposure,no matter how small, entails some elevation in risk of a fatal cancer induction. Statistically, the risks to a number of individuals can be added to determine an overall population risk. This makes intuitive sense where the individual risks are expressed at a level which appears to represent a tangible burden. For instance, a risk of 1 in 100 fatal cancer induction per year can be seen to represent an unacceptable lifetime risk. But a risk of 1 in 1 000 000 000 per year conveys little concept of real harm.
In addressing issues similar to these, the Health and Safety Executive (HSE 1992) employed a model to express concepts of the tolerability of risk (figure 1). At some upper level risks become 'unacceptable', where they cannot be justified other than in exceptional circumstances. At some lower level risks become 'broadly acceptable' when they are small in comparison to other everyday risks incurred; the actual level being determined by consideration of the ability of the individual to influence the risk and a balance between the risk of harm and any benefits gained. As a general rule of thumb, risks are considered to be broadly acceptable, for an individual, below about 10 −6 risk of dying per year. This value is not related directly to any economic cost or the value of an attributable death. For comparison, the risk of death from lightning strike in the UK is about 10 −7 y −1 (Morgan 1989) . Although useful conceptually, the tolerability of risk still leaves open the question of how a balance is to be made between the benefits and disbenefits arising both from the source of the risk and the measures which may be taken to reduce the risk. Furthermore, although pragmatic thresholds may be recognised in the tolerability of risk, it remains unclear as to whether real thresholds exist with respect to an individual's desire, or society's obligations, to reduce risk further.
This paper is concerned with the derivation of the economic value of saving a statistical life and with the application of this value to provide guidance on the control of risks to life. The values used in this paper are drawn from the general field of risk and life valuation, and they are intended to be illustrative only. However, it is believed that the broad approach presented will be of practical use in evaluating the cost-benefit of radiological protection measures.
Determining the value of a statistical life
The value of a statistical life (VSL) and its derivative the value of the spend to save a statistical life (VSSSL) are important in determining best use of resources, whether in the allocation of priorities in the health sector, the operation and regulation of industry or exploitation of the environment. But there are many issues surrounding the determination of a statistical life value such as age, life expectancy, ability to pay, quality of life and cultural norms. It is important to note that a statistical life does not relate to any identifiable person. In addition, there are recognised effects of particular risk aversions which result in the application of different VSSSLs. A notable instance is the aversion to large scale fatalities, such as occur in accidents. Thus, although aeroplane crashes and resultant fatalities are relatively uncommon by comparison to other modes of transport, the congregation of deaths in place and time gives such accidents a high salience and, accordingly, a much higher VSSSL per capita is derived (see, for example, the discussion on the effect of disaster aversion in CSERGE 1992).
Use of life valuation in regulation of the nuclear industry
The principles underlying regulation of the nuclear industry are generally founded in some form of balancing of the costs and benefits of a particular practice. The ICRP philosophy of maintaining discharges and exposures 'as low as reasonably achievable' (ALARA) contains the important provision that it be subject to economic and social factors. Similarly the regulatory tools of seeking best practicable means (BPM), best practicable environmental option (BPEO) and best available technology not entailing excessive cost (BATNEEC) all imply a balance of minimising impact against operational, technological, economic and other social practicalities. Nonetheless, regulation of the nuclear industry may be particularly exposed to pressure to minimise discharges, irrespective of cost, because of the explicit acceptance that exposure to radiation is linearly linked to a risk of death, with no threshold below which such exposure is accepted to have no impact. Indeed, the concept of 'collective dose' explicitly allows the addition of infinitesimally small doses across large populations (even populations separated in time) to calculate hypothetical risks of overall harm, although there is a body of scientific opinion suggesting that, at some level, the risk to an individual should be regarded as trivial 4 within the range of risks experienced through other, commonplace, activities (e.g. Clarke 1999). Consequently, if collective dose is to continue to form a tool for controlling impacts from the nuclear industry (as currently applied by both operators and regulators), an explicit and acceptable means of expressing the economic value of statistical lives saved is required which incorporates different risk levels. This study reviews the literature on the value of a statistical life and advances the concept of a risk related value of the spend to save a statistical life (VSSSL) for use in cost-benefit studies across the power generation sector.
Currency units
In deriving the VSSSL it is important to express all estimates in equivalent terms. For convenience, all monetary values are expressed here in £ sterling (2002 value) . Currency conversion rates are applied for the year in which the study was conducted, based on average exchange rates for that year. A constant rate of inflation of 4% per year is applied for all European, North American and Australasian studies over the period 1988 to present. Where the date of the study is uncertain, the date of publication is used as a surrogate.
Factors influencing the value of a life
There is no universally agreed estimate for the value of a statistical life. Following an extensive survey Viscusi (1992) suggested that most reliable estimates are clustered in the range £2.5-£5.9 million (M). In separate reviews of the literature Ball et al (1998) and Jackson and Rackham (2001) expressed uncertainty in valuation by adopting broad ranges of £0.5-£10 M. Considering the need to be able to project values into the future, Ball (2000) suggested that a simple order of magnitude range (i.e. £1-£10 M) provides an adequate representation. All three studies also concluded that for most applications a narrower range of £2-£4 M might be adopted.
Another study, by the EU DG Environment (European Union 2001), recommends the use of a somewhat lower value in the range £0.6-£2.2 M. Likewise the Health and Safety Executive (HSE 2001) have proposed a value of £1 M for adoption in all cases, except the prevention of a fatality from cancer where a value of £2 M is advanced.
It seems, on the basis of these studies that a VSL somewhere in the low £M region is likely to be appropriate under most circumstances. Nonetheless, a number of factors may influence the determination and application of the VSSSL. These are considered below.
Age
The DG Environment of the European Union (2001, p 2) argued that there 'are strong theoretical and empirical grounds for believing that the value for preventing a fatality declines with age'. However, from an actuarial viewpoint, with or without life-assured annuities, Johansson (2002) has shown that the picture may be far more complicated than this and it may be best to assume a relatively static life value over time. Furthermore, Moore and Viscusi (1988) advance the observation that the value of a 1 y life extension (e.g. from 70 to 71 y) may appear much higher to a 65 y old relative to a 35 y old.
In the most comprehensive study reviewed here, Krupnick et al (2000) elicited willingness to pay (WTP) responses from 930 residents of Ontario. They concluded that mean WTP estimates for risk reduction implied a VSSSL in the general range £600 k-£1.9 M. Age had no effect on WTP until roughly age 70 y. For the age group 70 + y the mean implied VSSSL was £300 k.
Given that standard age expectancies of the order of 70 y are routinely employed to convert life values to life year values and that most populations have a distribution of ages not likely to be dominated by the 70 + age group, it seems that age related effects on the VSSSL should not be taken routinely into account.
Voluntary and non-voluntary risks
There is a general consensus that risks are viewed differently if they result from voluntary activities. For instance, the risks from competing in sport are often discounted on the grounds that they involve primarily the individual and are balanced by positive benefits (including the concept of enjoyment).
This study is concerned with identifying a reasonable relationship between risk and the VSSSL for use in the nuclear industry and power generation in general. Comparison of risks across very broad divides, such as those represented by voluntary and non-voluntary activities, is not pursued further here.
Identifiable victim effect
There is a distinction to be made between an individual life and a statistical life. In the 1960s, Schelling (1968) pointed to the huge discrepancy in the USA between willingness to spend to assist an identified individual and, for instance, to support hospital programmes. More recently Jenni and Loewenstein (1997) examined factors contributing to the 'identifiable victim' effect; particularly media interest, background information and the vividness of empathic identification with the victim.
In rare instances the 'identifiable victim' effect can overlap with large accident aversion effects. The terrorist attack on the World Trade Centre in September 2001 may provide an example where both the number of deaths and the strong media profiling of the victims provided a combined stimulus for the USA administration to introduce a number of safety related acts without apparent regard to cost (see for instance Ripley 2002) . However, the VSSSL should be thought of as a convenient way to summarise the value of small reductions in statistical mortality risks. It is not meant to be applied to the value of saving the life of an identified person. Accordingly, the 'identifiable victim' effect, although real and significant, is not further taken into account for the purposes of setting a value on the spend to save a statistical life. Eeckhoudt and Hammitt (2001) consider it to be well established that the VSSSL increases with the magnitude of real or perceived mortality risk, and cite studies by Drèze (1964) , JonesLee (1974) and Weinstein et al (1980) in support of this. Where p (the probability of death) has a very large value, Pratt and Zeckhauser (1996) describe the 'dead anyway' effect. Almost any utility cost to decrease a very high p (the probability of death from a specific risk) may seem justified since there is an increasing chance that this will ultimately be drawn from the 'low marginal value state' (i.e. from the estate after death). This is an interesting way of looking at the problem where the individual is paying to achieve risk reduction. However, one might suppose a tendency for societal WTP to plateau at some level.
Magnitude of risk
Although no studies have been identified which address specifically how a diminishing risk affects WTP, this must apply as the converse case to increasing risk leading to increasing spend. Card and Krueger (1995) note that there is a tendency for the literature to under-report studies reporting non-significant relationships, or relationships contrary to current prevailing theory. Nonetheless, it seems clear that, as p approaches zero, the benefit of reducing p further will also approach zero and any cost would appear to constitute a net disbenefit.
This concept can be used to define pragmatic lower bounds on the value of further risk reduction. Eeckhoudt and Hammitt (2001) postulate that an individual's willingness to pay to reduce a specific mortality risk will be influenced by the existence, and characteristics, of other risks that person faces. Intuitively, in the presence of a large background risk there is little benefit in reducing other, marginal, effects. Eeckhoudt and Hammitt (2001) describe this as the 'why bother' effect since, if the aggregate of all risks (π) other than the specific large background risk ( p) is small, any reduction in π (assuming it to be independent of p) may be seen to be irrelevant.
Background risk
To understand the VSSSL attached to a specific risk, therefore, it seems that we should also understand the magnitude, and/or relative magnitude, of any competing risks of which an individual is aware. For the purposes of this study it is assumed that the specific risk of concern is valued independently of background risk.
Method of determination
There are a number of distinct approaches taken to the determination of the value of a statistical life. In a review of the literature Jackson and Rackham (2001) showed that estimates based on lifetime earnings potential generally yield lower life values than those based on willingness to pay or wage differential studies. Ball et al (1998) compared valuation based on consumer behaviour, contingent valuation and wage differentials, and identified a spread of values from less than £100 k to more than £20 M. An even more extreme spread of values was identified by Tengs et al (1995) , covering 11 orders of magnitude, and it seems that using any one method in isolation to estimate life values must be treated with caution. Slovic et al (1985) showed that people, as a whole, tend to underestimate the risks of common causes of death whilst overestimating risks from rare causes of death, unduly weighting measures of WTP. Likewise, the NRPB (1993) considered that WTP studies 'are inadequate to cope with unfamiliar or dread risks that are at levels which are initially hard to comprehend, and even more demanding to distinguish'. Again, Carthy et al (1999) noted that many studies fail to convey adequately to participants the magnitude of risk effects, with the consequence that exaggerated values for WTP may be elicited. Using a four stage approach to valuation they arrived at a VSSSL for UK road accidents around £1-£1.6 M; rather lower than many other studies. Introducing visual aids to convey risks and risk reductions, Corso et al (2001) estimated a VSSSL for US road accidents around £1.7-£4.1 M.
Safety decisions should reflect to some extent preferences in risk reduction targets but should not reflect errors in judgement and, for the purposes of this study, a range of techniques in determining the VSSSL were reviewed. Ball (2000) likewise concluded a preference for determining values based 'upon a broad appreciation of the outcomes from the various techniques which exist'.
Quality of life
Most life value estimates tend to assume an all or nothing approach. However, it is evident that, in many circumstances, morbidity or 'quality of life issues' will also be pertinent. This requires that life values can effectively be expressed on an annualised basis and that a measure of life quality can be introduced. For instance, undergoing surgery may affect both longevity and quality of life over the remaining lifetime. To take a practical example, suppose a person has an estimated ten years of life remaining without surgery, and a poor prognosis for quality of life (say 0.6, where 1.0 would be a 'normal' lifestyle). Following surgery, it is anticipated that longevity may be improved to 15 y and, for the whole period following surgery, the quality of life will also be improved (say, up to 0.8) The total 'quality adjusted life year' (QALY) benefit to the person is given by QALY = LE + QOL where LE is the longevity effect (5 × 0.8 quality of life) = 4 y and QOL is the quality of life effect (10 y × (0.8-0.6) = 2 y).
The overall benefit, adjusted for quality of life, can thus be expressed as 6 y. Clearly, this concept offers a number of advantages over a more absolute interpretation of life value although the quality of life factor remains highly subjective. A top athlete suddenly restricted to 'normal' activities may feel a substantial loss in quality of life.
Notwithstanding the difficulties in applying quality of life factors, the VSSSL approach developed here is compatible with introducing quality of life concepts, although in the context of regulating the nuclear industry risk is always expressed in terms of potential fatalities.
Wealth and societal expectation
Of the various co-variates investigated by Corso et al (2001) as contributory to implied VSSSL, only income appears to correlate positively. There may be a suggestion from this that, if ability to pay is linked to willingness to pay, studies in grossly poorer nations will inevitably indicate a lower VSSSL. In order to reduce this bias as far as possible, studies have been selected from Western Europe, North America, Australia and Japan. A comparison of studies conducted across these regions (figure 2) indicates extremely good agreement between estimates of the value of a statistical life, with an aggregation of values in the low £Ms.
It should be noted that figure 2 includes upper and lower ranges on the VSL where these have been presented in the original studies. This means that a number of outlying values for the VSL will be recorded. Where there are large numbers of studies, as for the UK and USA, the inclusion of these outliers will tend to balance out. However, for regions where fewer studies have been accessed in this review, the likelihood of sampling high or low VSL estimates is diminished. Consequently, the artefact that Canada, Europe, Australia and Japan produce fewer high estimates for the VSSSL is attributed entirely to the relatively few case examples reviewed from those regions. 
The effect of the date of study
In addition to wealth related biasing of societal expectations, there is the possibility that expectations may have varied with time as a reflection of cultural norms, giving rise to substantially differing estimates of the value of a statistical life. This review has sought to reduce the introduction of such a bias by restricting the timespan covered to 15 y (1988-2002) . A comparison of the VSL, derived from more than 60 separate studies, indicates that no trend can be identified over this period (figure 3). Indeed, given the simplistic assumptions concerning inflationary pressure, the agreement between years is quite remarkable.
As before, it should be noted that values presented in figure 3 include upper and lower range estimates produced in studies, hence some outlying values are expected. Nonetheless, even for the high estimates (where more variability may be expected) there is no evidence of a trend with time.
Applying modifying factors to radiological protection
For the purposes of valuing radiological protection measures, the NRPB (1993) accepted a median VSL equivalent to £2.5 M to imply a life year value of £50 k (assuming a rounded remaining life expectancy of 50 y). They further assumed that the value of the spend to save a life relates to a specific risk level, incorporating a multiplying factor. Although not stated explicitly it can be estimated that the NRPB believed a VSSSL of £2.5 M applies for risks around the level of 10 −3 per annum, since they stated that it equated to an average dose of 'a few millisieverts' 5 . The NRPB then presented a range of multipliers to be applied to baseline detriment costs as a function of annual individual dose. While the basis for this relationship was not made clear, it does have an intuitive appeal and is illustrated in figure 4 .
If a VSSSL of £2.5 M applies at a risk level of 10 −3 y −1 , inclusive of a multiplying factor around 5, then at risk levels around 10 −6 (or a dose of 15-20 µSv) a more appropriate VSSSL would be £0.5 M, with a life year value of £10 k.
Finally, the NRPB argued that if average individual doses can be characterised approximately, then a value can be set on units of collective dose. If a dose of 1 man Sv gives rise to approximately three years' loss of life on an unweighted averaged basis then, for an average dose around a few microsieverts to each individual, the value of 1 man Sv collective dose will be around £30 k. Given that critical group doses deriving from UK nuclear sites do not generally exceed a few tens of microsieverts per year it is a reasonable assumption that collective doses can be typified by low individual exposures.
Should a single VSSSL be applied in all situations?
It has been seen that estimates of the VSSSL may vary for a number of methodological and social reasons. Nonetheless, Kenkel (2001) argues that it is desirable that different regulatory agencies should use the same VSSSL when they are evaluating similar life-saving benefits. Thus, in the context of the power generation sector, regulation based on a cost-benefit approach should apply a uniform value of saving a statistical life irrespective of the form of power generation (oil, coal, gas, nuclear, thermal, wind, solar etc). However, different undertakings often result in fundamentally different types of life-saving benefits (spends on hospitals, roads and sewer maintenance, for example, impact on human health in radically different ways). The question remains whether the application of a single VSSSL is appropriate across these different sectors. We believe that a single value can be applied. Nonetheless, two sources of heterogeneity in determining the VSSSL may be noted. First, in the willingness of an individual to pay across different health risks. Second, across individuals in willingness to pay for risk reductions. Individual willingness to pay for a given reduction in mortality risks probably differs depending on the cause of death, although empirical evidence to support this contention appears to be fairly limited. Jones-Lee et al (1985) reported that preventing deaths due to cancer is valued at about twice that of preventing heart disease and three times that of preventing motor vehicle accidents. Tolley et al (1994) and Kenkel (2001) suggest that this may reflect a perceived additional detriment where morbidity precedes mortality. In other words, an implicit quality of life factor is being applied. In this study, values of the spend to save a statistical life are advanced based on the general literature (figure 5). It is considered that this will be applicable where cost-benefit analyses or comparisons are limited to non-specific risks to members of the public from industrial operations.
Of 70 + mid-point estimates of the VSL nearly 40% lie in the range £1-£3 M and 75% do not exceed £5 M. There is thus reasonable justification for adopting the suggestion of the Nuclear Safety Directorate of the Health and Safety Executive (HSE 2001 , NSD 2002 ) that a VSL of £2 M be adopted, recognising that the arithmetic mean VSL of £3.6 M is somewhat skewed by the range of higher values. However, it seems clear that a range for the VSL of £1-£5 M will not introduce serious bias into any cost-benefit study and will not lead to underestimates of the VSSSL where comparison across industrial sectors is required or where a sensitivity analysis is to be conducted. In accepting some imprecision around the best estimate we also accept that the VSSSL is an aid to decision making and that other factors will influence fine tuning.
Individual risk and 'de minimis'
Paté-Cornell (2002) noted that risk-management decisions in the US courts have generally been obliged to ignore cost issues 'because the US Supreme Court has said so'. The corollary tends to be that if no cost limit is set, a de minimis threshold for risk is required below which the law does not concern itself, since it is clear fact that all resources (even those of the American economy) are finite. For individual risks, the de minimis threshold seems to gravitate around one in a million per year (Paté-Cornell 1994) . This is in keeping with UK guidance on the disposal of radioactive wastes (e.g. Cmnd 2919, 1995) where 'one in a million per year' defines a broadly acceptable lower risk band, below which further reductions will not be sought by the regulators (subject to the provisions of best practicable means being employed).
The concept of a de minimis threshold suggests that further reduction of individual risk below this level has no economic benefit value. It is not that the value of a life is altered below this threshold. Rather, the benefit of further risk reduction must be regarded as negligible where the original risk itself is classed as being below the level of concern.
In fact, it is doubtful whether an absolute attitude towards a de minimis threshold could be maintained and Paté-Cornell (2002) suggests that 'some flexibility in the decision criteria' is required. For instance, the US Environment Protection Agency (Thompson 2002 ) has defined its lower threshold of concern as the 99.9th percentile exposed individual. In other cases, this might include instances where a large number of people are exposed to very small risks and the concept of collective dose might adopt a risk threshold below the de minimis level for each individual (e.g. Clarke 1999) . The guiding rule here should be, 'what is reasonable'. It is suggested that a pragmatic approach be adopted with no explicit de minimis but, below some risk factor, a nominal VSSSL is retained. As a first pass estimate, a risk threshold of 10 −9 y −1 (i.e. two orders of magnitude below the risk from lightning strike) is proposed, below which the VSSSL remains constant but low.
Estimating uncertainty
It has been discussed in the previous sections that the apparent value of saving a statistical life may vary as a function of the method of determination or the proposed area of application.
A further factor to be considered as an input to a balanced decision making process is the uncertainty or ambiguity around central VSSSL estimates. Thompson (2002) made the distinction that variability represents real differences within a population, whereas uncertainty expresses our imperfect state of knowledge. Unfortunately, economic risk analysis is seldom performed on the basis of large statistical databases and the quantification of distribution functions, with defined confidence intervals, is rarely possible. Consequently, in this study we refer only to uncertainty. In the absence of sufficient statistics, or of a firm understanding of basic principles, an alternative approach to risk management may be to require a 'zero risk', without any reference to practicability, let alone an attempt to quantify the benefits. One consequence of such a policy is that no prioritisation of actions can be made and, as Paté-Cornell (2002) suggests, 'when there are clear resource constraints to the implementation of such policies, better risk assessment methods are needed, even if they include an element of subjectivity'.
The results of a risk analysis are generally meant to answer two kinds of questions.
• Is a particular risk broadly acceptable?
• What measures can be adopted reasonably to minimise risk within resource constraints?
Both questions need to include aspects of the magnitude of the risk and its controllability. Understanding uncertainty pertaining to both the risk and the benefit can be an important part of the decision making process. Preliminary sensitivity analysis may be undertaken by adopting extreme values, but this may skew inappropriately the decision making process due to a single outlying study. Even less extreme conservatism, if applied at each successive stage of a risk determination, can perturb the ranking of risks or the balance of risks and benefits. In this study, a range on the VSSSL is set based on the broad consensus of literature, expressed through mean and median estimates.
Excessive VSSSL and loss of life models
Any regulation intended to save life may also introduce risks not previously apparent. It has been argued by Thompson (2002) that the introduction of air bags into cars was an engineering solution to a behavioural problem (not wearing seat belts). On balance, air bags do save lives, but they also present a hazard to small individuals (such as children). Consequently, legislation to control behaviour (restricting children sitting in fronts seats) has been introduced to counter the hazard from the engineered solution (Thompson 2002 ). This scenario is not as bizarre as it sounds; the net balance is clearly skewed towards the reduction of road accident fatalities. However, it illustrates the point that regulatory burdens require life-cycle impact analyses.
To take a less clear-cut example, personal wealth is linked positively to health and life expectancy. Likewise, national domestic product determines the ability of a state to spend on health, education and social welfare. Consequently, there is a well established principle that reduction of disposable income introduces an indirect mortality effect on populations. Logically, the cost of introducing regulations intended to save life may therefore also introduce some loss of life. At some point, the balance of cost and benefit will imply that regulations may cause a net loss of life.
In a study of 40 000 Swedes, followed through for 10-17 y, controlling for income, initial health, education and many other variates, Gerdtham and Johannesson (2002) estimated the impact of regulations which introduce very high estimates of the VSSSL. Their study concludes that the income loss that will induce an expected fatality is £4.5 M when the costs are borne equally among all adults and £5.6 M when the costs are borne proportionately to income. For the purposes of sensitivity analyses they further suggest that a range of values of £1.8-£17 M be employed.
The mean values proposed by Gerdtham and Johannesson (2002) at which the spend on regulations intended to save life becomes counterproductive is somewhat lower than previous studies, mainly conducted in the USA. For instance, Lutter et al (1999) estimated a value of £13.6 M.
Whilst there may be some real cultural differences, the study by Gerdtham and Johannesson (2002) is probably the most comprehensive and best controlled available, and suggests the adoption of a threshold mean VSSSL of £5 M, above which net loss of life may be incurred.
Establishing a risk-VSSSL relationship
The preceding discussion has identified a number of factors influencing the value of a statistical life and factors influencing the perceived risk from activities. There is a clear, but unquantified, relationship between risk and the VSSSL. This relationship is affected by individual variability in such areas as willingness to pay, the magnitude of background risks, age, the proportion of risk averted, the method used to determine life values and straightforward uncertainty (i.e. the sum of all sources of variability which have not been identified individually).
Nonetheless, a number of fixed parameters have also been identified. A life value can be set beyond which further spend by society will result in a net detriment. Since the whole approach to valuing statistical life is essentially utilitarian (resulting in 'the greatest good to the greatest number') net detriments must be rejected. At some lower point, where risks from any specified activity approach zero, the value of spending to further decrease the risk also tends towards zero.
From these fixed parameters, a number of qualitative risk-life value models can be proposed.
The simplest assumption might hold that the relationship between risk and the VSSSL is linear, with no lower threshold, up to a maximum value at a risk factor of 1. This forms a direct analogy with the linear no-threshold dose-risk response relationship used to govern risk assessments. In this model, the VSSSL reaches a peak value only at the maximum risk and, intuitively, this appears overly simplistic in most cases. It may have particular merit where background risks are high (such that averting the specific risk of concern has an increasing value as it approaches or exceeds the pre-existent risk). In most cases, however, it is considered likely that as risk reaches a high value the VSSSL to reduce the risk will to rise to the maximum determined value.
This approach might represent an individual's VSSSL. However, it is equally likely that as the risk approaches 1 an individual would be willing (if not necessarily able) to pay grossly disproportionately in order to reduce risk (the so-called 'dead anyway' effect discussed earlier, which relies partly on the fact that actual cost is likely to be drawn from the dead persons estate so the probable utility cost to the living person of a disproportionate spend is virtually zero). For society, dealing with the value of the spend to save a statistical life, it can be argued that as the risk approaches unity continuing to spend to avert a virtual certainty has little merit (similar to the 'why bother' effect discussed previously).
Whilst an 'optimum spend' model appeals to a strictly utilitarian outlook, it is likely (even if it cannot be demonstrated quantitatively) that the risk would have to be very high before decisions to reduce the spend to avert some fraction of the risk would attract consensus support. Consequently, the overall shape of a risk-VSSSL relationship may resemble a non-linear, but unbounded model, such as illustrated in figure 6 .
Finally, in considering qualitative models for the relationship between risk and the VSSSL, the special case of distinguishing between perceived risk and actual risk should be considered. It has been discussed that perceptions of risk can be very poor, both with respect to absolute magnitude and relative risk assessment. Equally, a small spend remains a small spend, irrespective of the risk. Thus an individual may appear to overvalue life against small risks simply because the cost of risk reduction is low. At the extreme, it would be possible to present an apparent risk-VSSSL relationship as in figure 7.
Although this model should not be dismissed summarily, as it may represent real spend decisions made by individuals, it does not appear to offer a reasonable approach to determining spend by public or private bodies to avert risks on an equitable basis where spend priorities are required.
Whilst it is acknowledged that the above is an entirely qualitative discussion of possible models, there is an intrinsic logic about the non-linear model for risk versus VSSSL. At very low risks, the value of any further reduction will also be very low and, in the context of all other life risks, the effect of reducing the specific risk under consideration is likely to be negligible with respect to decision making processes. Consequently, the risk-VSSSL relationship is sublinear at very low risks. By contrast, at very high risks (where the specific risk under consideration becomes significant by comparison to other life risks) the willingness of society to spend is likely to reach a near maximum value and then plateau. In between these two (as yet unquantified points) the risk-life value relationship will become superlinear. Before attempting to place quantified benchmarks onto this discussion, one further consideration must be incorporated. That is, the variability surrounding appropriate VSLs to derived VSSSL. It is clear from preceding sections that no single VSL can be advanced with any expectation of universal support. Consequently a range in the value of the spend to save a statistical life must be expressed at the upper end of the risk factors, and it is likely that the range will reduce in some proportionate fashion as the risk diminishes until, at the limit, a zero VSSSL applies.
The value of a statistical life, applicable to the UK and other western countries, has been established with reasonable certainty to lie in the range £1-£5 M, irrespective of the method of determination 6 . These will be the range of values adopted as p (the probability of loss of life from a specific risk) tends to 1. No fixed rules exist to establish where p becomes sufficiently of concern that the maximum VSSSL should be incurred by society. Likewise, there is no certainty on the appropriate value of p to determine when an individual is unlikely to be significantly concerned about either the absolute or the relative risk posed. However, there is evidence, as discussed in the preceding sections, that practical upper and lower values of p can be established.
Broadly, there is consensus that a risk of less than one in a million per year would be regarded as acceptable. Similarly, a risk exceeding one in one thousand would be regarded as unacceptable. This upper value for p is less intuitively obvious than the lower value, as appropriate points of comparison become confused. However, a relatively simple sum appears to support the use of a 10 −3 risk per year as the upper step change. If we assume (simplistically) a life expectancy of 100 y, a risk of 10 −3 y −1 represents a 10% likelihood of death from that factor over a lifetime. The imposition of an additional burden of this order, over a lifetime, can be seen to be significant.
At the very lowest end, the risk at which further risk reduction is ascribed a nominal residual value remains arbitrary and is set here at 10 −9 y −1 (i.e. two orders of magnitude below the estimated risk of death from lightning strike). A practical application of this approach is illustrated in figure 8 .
In defining this relationship, it must be remembered that the derivation of a VSSSL does not imply the worth (or merit) of any individual, but sets a common factor allowing for decision making in the prioritisation of spends to reduce the probability of fatalities occurring from an activity. Viewed in this sense, there is again an intuitive feel that the proportionate spend to be incurred in reducing already low risks should be less than the spend justified as risks become higher. That is, in decision making, the reduction of a single source of risk of magnitude 10 −3 y −1 should merit prioritisation over the reduction of 1000 activities each giving rise to a risk of 10 −6 y −1 . Furthermore, it is assumed here that background risk remains roughly constant.
In the specific case of regulation of the nuclear industry, the risk-VSSSL relationship proposed above can also be represented in terms of dose-VSSSL (since dose and risk are assumed to be linked in a simple linear fashion). Taking mid-point estimates only, a dose incurred at the annual dose limit for a member of the public (1 mSv), with a risk approaching 10 −4 y −1 , would imply a VSSSL of £1.5 M. Below 0.01 µSv y −1 (in round terms a risk below 10 −9 y −1 ) a nominal VSSSL of £0.01 M is applied here. At about 10 µSv y −1 (in round terms a risk approaching 10 −6 y −1 ) a corresponding value around £0.5 M is derived. Given that the model presented is subject to considerable uncertainty, it may be appropriate to give a VSSSL range of £0.25-£1 M. If it is assumed that individual dose contributions to collective dose will lie normally in the region of a few microsieverts, a monetary value expressed per man Sv can be derived. For a risk of 0.06 Sv −1 exposure, 1 man Sv represents a theoretical loss of approximately 3 life years, with a value (based on a VSSSL of £0.25-£1 M and a mean remaining life expectancy of 50 y) £15-£60 k. Perhaps reassuringly, this value is essentially unaltered from that proposed by the NRPB (1993), adjusted for inflation, for use in cost-benefit analyses through the 1990s.
Using the model proposed above, collective dose remains a useful tool in cost-benefit analyses to determine priorities between spends to reduce risk, and to determine justifiable limits on the spend for any given risk. By way of an example of the use of this approach, table 1 illustrates the collective dose arising from Sellafield under a specific set of assumptions regarding future operations.
The collective doses arising have been calculated in broad bands representing the average dose to individuals contributing to the total collective dose. Three dose avoidance values are calculated. In the first case, a VSSSL of £2 M is applied uniformly across all average individual dose categories. This is essentially the current approach to such a calculation. In Uniform VSSSL £2 000 000 £2 000 000 £2 000 000 £2 000 000 £2 000 000 Uniform VSSSL, with threshold for very low doses £10 000 £2 000 000 £2 000 000 £2 000 000 £2 000 000 Risk related VSSSL £10 000 £250 000 £500 000 £750 000 £1 500 000 Justifiable spend (A × £B) Uniform VSSSL £420 000 000 £13 200 000 £2 000 000 £2 400 000 £1 440 000 £439 040 000 Uniform VSSSL, with threshold for very low doses £2 100 000 £13 200 000 £2 000 000 £2 400 000 £1 440 000 £21 140 000 Risk related VSSSL £2 100 000 £1 650 000 £500 000 £900 000 £1 080 000 £6 230 000 this case, a spend value of greater than £400 M appears to be justified. In the second case, a VSSSL of £2 M is applied uniformly to all categories with an average individual dose greater than 0.015 µSv. For the very low dose group a VSSSL of £0.01 M is applied. This implies a justified spend of £21 M, indicating the dominant impact of the very low dose group. In the last case, the risk related VSSSLs presented in this paper have been applied and the implied justified spend reduces again, to about £6 M. If collective dose is to continue to be used to aid decision making in the prioritisation of introducing radiological protection measures, the application of monetary values to a statistical life requires further consideration. It is emphasised that this paper provides an outline concept only, and that all values chosen are illustrative (although considered to be reasonably well supported from the literature where appropriate). It is hoped that this will prove useful in developing further cost-benefit analyses as an aid to decision making.
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Appendix. Glossary of terms and abbreviations

ALARA
As low as reasonably achievable. The principle by which radiological doses are reduced to a level that represents a balance between risks and other factors, including social and economic factors. As laid out in ICRP Publication 60 'this procedure should be constrained by restrictions on doses to individuals (dose constraints), or the risk to individuals in the case of potential exposures (risk constraints), so as to limit the inequity likely to result from the inherent economic and social judgements'. BATNEEC Best available technology not entailing excessive cost. The principle which determines the level of protection to be provided under Integrated Pollution Control, introduced in the UK in the 1990 Environmental Protection Act. This has been replaced by BAT (Best Available Technology) set out in the Integrated Pollution Prevention and Control Directive, 1996. BPEO Best practical environmental option. The most effective means of preventing, minimising or rendering harmless polluting emissions based on a holistic assessment of impacts, availability of processes, social and economic concerns. BPM B est practicable means. The forerunner of BATNEEC, placing a requirement on both the provision and maintenance of appliances and practices to prevent the release of noxious materials particularly, under section 5 of the Health and Safety at Work Act (1974), for the control of atmospheric emissions. CBA Cost-benefit analysis. A term used to describe a quantified evaluation which seeks to express in monetary terms as many of the costs and benefits of a proposal as possible, including items for which the market does not provide a satisfactory measure of economic value. 
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